"You decide and we provide."
Cart 0

BRIEF-Genentech announces positive interim results for Emicizumab in phase III study of children with Hemophilia A




reutersCOMPANYNEWS companyNews

* Genentech announces positive interim results for Emicizumab in phase III study of children with Hemophilia A




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published